Nessa Carey
Impact in
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Muscle Physiology and Disorders
- Mitochondrial Function and Pathology
-
- Genetic Neurodegenerative Diseases
Papers in
-
- Genetic Neurodegenerative Diseases 13
- Co-authors
- Keith JohnsonJonathan D. BestMichael JeffersXiaozhong QianJames W.A. RitchieCraig HackettNagma KhanMaxwell Sehested
- Journals
- Drug Discovery Today (3 papers)Biochemical and Biophysical Research Communications (3 papers)Genomics (3 papers)Journal of Medical Genetics (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Nessa Carey
35 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Molecular Biology 1.2k
- Cellular and Molecular Neuroscience 298
- Microbiology 48
- Virology 35
- Oncology 194
Countries citing papers authored by Nessa Carey
This map shows the geographic impact of Nessa Carey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nessa Carey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nessa Carey more than expected).
Fields of papers citing papers by Nessa Carey
This network shows the impact of papers produced by Nessa Carey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nessa Carey. The network helps show where Nessa Carey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nessa Carey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 20 | |
| 2 | Epigenetics in actions: Part 2 : Turn-ons and turn-offs. | 2012 | 1 |
| 3 | 2011 | 32 | |
| 4 | 2010 | 23 | |
| 5 | 2009 | 65 | |
| 6 | 2009 | 43 | |
| 7 | 2007 | 0 | |
| 8 | 2004 | 8 | |
| 9 | 2002 | 14 | |
| 10 | 2001 | 14 | |
| 11 | 2001 | 11 | |
| 12 | 2001 | 7 | |
| 13 | 2000 | 107 | |
| 14 | 1998 | 29 | |
| 15 | 1998 | 9 | |
| 16 | 1996 | 45 | |
| 17 | 1996 | 55 | |
| 18 | 1995 | 147 | |
| 19 | 1995 | 52 | |
| 20 | 1994 | 5 |
About Nessa Carey
Nessa Carey is a scholar working on Cellular and Molecular Neuroscience, Developmental Biology, Virology, Molecular Biology and Immunology and Allergy, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (13 papers), Mitochondrial Function and Pathology (6 papers), Muscle Physiology and Disorders (6 papers), Epigenetics and DNA Methylation (6 papers), Histone Deacetylase Inhibitors Research (5 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Ion channel regulation and function (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Cellular and Molecular Neuroscience (298 citations), Microbiology (48 citations), Virology (35 citations) and Oncology (194 citations). Nessa Carey has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Keith Johnson, Jonathan D. Best, Michael Jeffers, Xiaozhong Qian, James W.A. Ritchie, Craig Hackett, Nagma Khan, Maxwell Sehested, Henri S. Lichenstein and Ferenc Boldog. Their work appears in journals such as Drug Discovery Today, Biochemical and Biophysical Research Communications, Genomics, Journal of Medical Genetics and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.